Skip to main content

Table 5 Morbidity and mortality in dependency of diagnosis

From: Retrospective analyses of trends in pancreatic surgery: indications, operative techniques, and postoperative outcome of 1,120 pancreatic resections

  PDAC Periampullary carcinoma Chronic pancreatitis pNET IPMN Other P value
( n= 380) ( n= 160) ( n= 360) ( n= 48) ( n= 42) ( n= 125)
Mortality 16 (4.2%) 4 (2.5%) 5 (1.4%) 0 (0.0%) 2 (4.8%) 0 (0.0%) <0.05
Overall morbidity 194 (51.1%) 101 (63.1%) 161 (44.1%) 22 (45.8%) 25 (59.5%) 75 (60.0%) <0.001
Operation-related morbidity 131 (34.5%) 76 (47.5%) 121 (33.2%) 23 (47.9%) 23 (54.8%) 70 (56.0%) <0.001
Reoperation 40 (10.5%) 21 (13.1%) 35 (9.6%) 6 (12.5%) 11 (26.2%) 14 (11.2%) <0.05
Pancreatic fistula grades A to C 70 (18.4%) 62 (38.8%) 68 (18.6%) 23 (47.9%) 15 (35.7%) 58 (46.4%) <0.001
  1. Number (percentage). PDAC, pancreatic ductal adenocarcinoma; pNET, primitive neuroectodermal tumor; IPMN, intraductal papillary mucinous neoplasm.